Exemptia 40

Supported by huge market experience, we are the famous Exporter, Distributor & Supplier of Exemptia 40 in Madurai, Tamil Nadu, India. Adalimumab, trade name Exemptia, is a potent TNF-inhibitor and anti-inflammatory drug manufactured and promoted by Zydus Cadila in India. When people have Rheumatoid Arthritis or other inflammatory diseases, it causes over-secretion of TNF, a protein naturally produced in the body, causing inflammation and damage to the joints. Adalimumab works as anti-TNF, blocking over production of TNF and its harmful effects on the body. It helps to reduce inflammation and alleviate the symptoms of arthritis and other joint disorders. Adalimumab is available only on prescription from a Rheumatologist. The side effects are not serious and generally go away in few hours after taking the injection.